I agree. In the past I’ve been a heavy suppor
Post# of 148304
In the past I’ve been a heavy supporter of NP, but my patience is wavering. The videos this week offered little in terms of an update and keeping quiet would’ve been better. I’m getting tired of the comparisons to Humira and Truvada; we get it, he thinks leronlimab will be valuable but it doesn’t mean anything right now. ZERO.
IMO, NP and CYDY should keep quiet until the information they have is PR worthy. The videos and interviews don’t appear to increasing investor interest and instead decrease the SP when NP’s wording of topics concerns investors.